EchoTip AcuCore Post-Market Clinical Study

CompletedOBSERVATIONAL
Enrollment

183

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

June 14, 2025

Study Completion Date

July 19, 2025

Conditions
AdenocarcinomaNeuroendocrine TumorsHepatocellular CarcinomaCholangiocarcinomaMalignant LymphomaMetastasisChronic PancreatitisAutoimmune Pancreatitis
Interventions
DEVICE

EchoTip AcuCore

Using endoscopic ultrasound guided needle to collect biopsies

Trial Locations (8)

17822

Geisinger Medical Center, Danville

22908

University of Virginia, Charlottesville

32610

Shands Hospital-University of Florida, Gainesville

University of Florida Shands Hospital, Gainesville

32803

Advent Health Medical Group, Orlando, Orlando

77030

University of Texas Memorial Hermann Hospital, Houston

80210

Advent Health, Porter, Denver

92868

University of California, Irvine, Orange

All Listed Sponsors
lead

Cook Research Incorporated

INDUSTRY

NCT06358001 - EchoTip AcuCore Post-Market Clinical Study | Biotech Hunter | Biotech Hunter